Fundies.
English

AMPIO PHARMACEUTICALS, INC.

EDGAR
AMPE Annual report (10-K) · filed 2024-03-27

115 filing records in this dataset, filed from 2007-11-14 to 2024-03-27. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

469 thousand USD

2015 Q4 · USD

Exact inputs and evidence

Operating margin

-2,196.88%

2015 Q4 · %

Exact inputs and evidence
  • Operating Income: -33302119 USD Source
  • Operating Income: -22994062 USD Source
  • Revenue: 469213 USD Source

Operating cash flow

-7.77 million USD

2015 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -26444110 USD Source
  • Operating Cash Flow: -18678538 USD Source

Free cash flow

-7.77 million USD

2015 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -26444110 USD Source
  • Operating Cash Flow: -18678538 USD Source
  • Capital Expenditure: 110495 USD Source
  • Capital Expenditure: 108709 USD Source
Cash and cash equivalents
4.1 million Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A Source
Exact value

4100000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A

Long-term debt including current maturities
Not available
Shares outstanding
833 thousand Unit_Standard_shares_lONSRrX6pkOTA2yqjm0A5w Source
Exact value

833430 Unit_Standard_shares_lONSRrX6pkOTA2yqjm0A5w

Reported share-count change

3.57% · 28.8 thousand Unit_Standard_shares_lONSRrX6pkOTA2yqjm0A5w

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 804674 Unit_Standard_shares_lONSRrX6pkOTA2yqjm0A5w · 2022-12-31· Source
  • 833430 Unit_Standard_shares_lONSRrX6pkOTA2yqjm0A5w · 2023-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.16 million USD

2015-01-01 – 2015-12-31

Exact inputs and evidence
  • Revenue: 21429 USD · 2015-01-01 – 2015-03-31 Source
  • Revenue: 184435 USD · 2015-04-01 – 2015-06-30 Source
  • Revenue: 487385 USD · 2015-07-01 – 2015-09-30 Source
  • Revenue: 469213 USD · 2015-10-01 – 2015-12-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-03-27.

Financial data available through: 2023-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2015-12-31
  • Operating income: 3 of 11 periods available· newest 2015-12-31
  • Net income: 2 of 11 periods available· newest 2023-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2023-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2022-12-31
  • Total assets: 2 of 11 periods available· newest 2023-12-31
  • Total liabilities: 2 of 11 periods available· newest 2023-12-31
  • Current assets: 2 of 11 periods available· newest 2023-12-31
  • Current liabilities: 2 of 11 periods available· newest 2023-12-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2023-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 2 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 7.71 million

    Prior period

    −Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 16.34 million

    –

    Current period

    −Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 8.63 million

    –

    Exact inputs and evidence

    -8632000 − -16337000 = 7705000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A

    -16337000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -8632000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 12.56 million

    Prior period

    −Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 21.13 million

    –

    Current period

    −Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 8.56 million

    –

    Exact inputs and evidence

    -8564000 − -21128000 = 12564000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A

    -21128000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A · 2022-01-01 – 2022-12-31

    Inspect prior input Prior source

    -8564000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A · 2023-01-01 – 2023-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2015 2015-01-01 – 2015-12-31

  • Revenue USD 1.16 million 100% of revenue
  • Operating costs Derived USD 34.46 million 2,965% of revenue
  • Operating income −USD 33.3 million −2,865% of revenue
  • Tax, interest and other Derived Unavailable An input is unavailable.
  • Net income Unavailable An input is unavailable.

Cash

  • Operating cash flow Unavailable An input is unavailable.
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2013 Not shown: operating income or net income is not reported.
  • 2014 Not shown: operating income or net income is not reported.
  • 2015 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2013 2013-01-01 – 2013-12-3150000 24073873 Derived -24023873 UnavailableUnavailableUnavailable
Source
2014 2014-01-01 – 2014-12-3176787 39147822 Derived -39071035 UnavailableUnavailableUnavailable
Source
2015 2015-01-01 – 2015-12-311162462 34464581 Derived -33302119 UnavailableUnavailableUnavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.2M 2015
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.3M941.6K627.7K313.9K0.0201320142015
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Revenue50000
2014Revenue76787
2015Revenue1162462

Revenue growth

Change in revenue from the same financial period one year earlier.

1,413.9% 2015
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,527%1,145%763%382%0%201320142015
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2013Year over yearNo prior comparable period
2014Year over year53.6%
2015Year over year1,413.9%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2,864.8% 2015
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4,071%-10,685%-25,441%-40,197%-54,953%201320142015
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2013Operating margin-48,047.7%
2014Operating margin-50,882.4%
2015Operating margin-2,864.8%
2013-12-31Net marginNot reported
2014-12-31Net marginNot reported
2015-12-31Net marginNot reported
2013Free cash flow marginNot reported
2014Free cash flow marginNot reported
2015Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Operating cash flowNot reportedNo source recorded
2014Operating cash flowNot reportedNo source recorded
2015Operating cash flowNot reportedNo source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValueSource evidence
2013Free cash flowUnavailableNo source recorded
2014Free cash flowUnavailableNo source recorded
2015Free cash flowUnavailableNo source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2013-12-31Liabilities / assetsNot reportedNo source recorded
2014-12-31Liabilities / assetsNot reportedNo source recorded
2015-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2013-12-31Current assets / current liabilitiesNot reportedNo source recorded
2014-12-31Current assets / current liabilitiesNot reportedNo source recorded
2015-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2022 2022-01-01 – 2022-12-31
−Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 16.34 million
Exact value

Exact value: -16337000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A

2022-01-01 – 2022-12-31: -16337000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 21.13 million
Exact value

Exact value: -21128000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A

2022-01-01 – 2022-12-31: -21128000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2023 2023-01-01 – 2023-12-31
−Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 8.63 million
Exact value

Exact value: -8632000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A

2023-01-01 – 2023-12-31: -8632000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A 8.56 million
Exact value

Exact value: -8564000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A

2023-01-01 – 2023-12-31: -8564000 Unit_Standard_USD_5Azhe-9YdUScaWJFKH9g4A Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

115 filings · 3,715 latest values · 3,698 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001411906, 1411906, AMPE, edgar:1411906

Also known as AMPIO PHARMACEUTICALS, INC., AMPIO PHARMACEUTICALS, INC., Ampio Pharmaceuticals, Inc., Chay Enterprises, Inc.